Hexadecylamine - CAS 143-27-1
Catalog: |
BB009539 |
Product Name: |
Hexadecylamine |
CAS: |
143-27-1 |
Synonyms: |
hexadecan-1-amine |
IUPAC Name: | hexadecan-1-amine |
Description: | Hexadecylamine (CAS# 143-27-1) is a building block that is used as an expanding agent. |
Molecular Weight: | 241.46 |
Molecular Formula: | C16H35N |
Canonical SMILES: | CCCCCCCCCCCCCCCCN |
InChI: | InChI=1S/C16H35N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h2-17H2,1H3 |
InChI Key: | FJLUATLTXUNBOT-UHFFFAOYSA-N |
Boiling Point: | 330 °C |
Melting Point: | 38-47 °C |
Flash Point: | 140°C |
Purity: | 90 % |
Appearance: | A white waxy solid with an ammonia-like odor. insoluble in water and less dense than water. hence floats on water. contact may irritate skin, eyes and mucous membranes. may be toxic by ingestion, inhalation or skin absorption. used to make other chem |
Storage: | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage. |
MDL: | MFCD00008158 |
LogP: | 6.12670 |
Refractive Index: | 1.4496 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P260, P264, P270, P273, P280, P301+P310, P301+P312, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P314, P321, P330, P331, P363, P391, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
US-10874687-B1 | Highly active compounds against COVID-19 | 20200227 |
US-2021189035-A1 | Acrylate Copolymer and Use Thereof | 20191220 |
WO-2021126264-A1 | Inkjet inks | 20191220 |
WO-2021126644-A1 | Acrylate copolymer and use thereof | 20191220 |
EP-3838891-A1 | Aldimines and uses thereof | 20191219 |
PMID | Publication Date | Title | Journal |
29968805 | 20180703 | Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | Scientific reports |
26810833 | 20160215 | Synthesis and anti-tuberculosis activity of glycitylamines | Bioorganic & medicinal chemistry |
23043267 | 20121031 | The big impact of a small detail: cobalt nanocrystal polymorphism as a result of precursor addition rate during stock solution preparation | Journal of the American Chemical Society |
23057722 | 20121030 | Directed coassembly of oriented PbS nanoparticles and monocrystalline sheets of alkylamine surfactant | Langmuir : the ACS journal of surfaces and colloids |
22917192 | 20121017 | Ostwald's Rule of Stages and its role in CdSe quantum dot crystallization | Journal of the American Chemical Society |
Complexity: | 123 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 241.276950121 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 241.276950121 |
Rotatable Bond Count: | 14 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 7.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS